Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 15;77(2):196-202.
doi: 10.1016/j.biopsych.2013.02.017. Epub 2013 Mar 27.

Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index

Fernando Caravaggio  1 , Sofia Raitsin  1 , Philip Gerretsen  2 , Shinichiro Nakajima  3 , Alan Wilson  2 , Ariel Graff-Guerrero  4
Affiliations

Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index

Fernando Caravaggio et al. Biol Psychiatry. .

Erratum in

  • Biol Psychiatry. 2015 Mar 15;77(6):597

Abstract

Background: Positron emission tomography research has shown that dopamine D2/3 receptor (D2/3R) availability is negatively correlated with body mass index (BMI) in obese but not in healthy subjects. However, previous positron emission tomography studies have not looked specifically at the ventral striatum (VS), which plays an important role in motivation and feeding. Furthermore, these studies have only used antagonist radiotracers. Normal-weight rats given free access to high-fat diets demonstrate behavioral sensitization to D2/3R agonists but not to antagonists. Sensitization is associated with increased D2/3R affinity, which affects binding of agonists but not antagonists.

Methods: We examined the association between BMI within the nonobese range (18.6-27.8) and D2/3R availability in the VS with the use of the agonist radiotracer [(11)C]-(+)-PHNO (n = 26) and the antagonist [(11)C]-raclopride (n = 35) in healthy humans.

Results: In the VS, we found a positive correlation between BMI and [(11)C]-(+)-PHNO binding but no relationship with [(11)C]-raclopride binding. Secondary analyses revealed no relationship between BMI and binding in the dorsal striatum with either radiotracer.

Conclusions: We propose that in nonobese individuals, higher BMI may be associated with increased D2R affinity in the VS. This increased affinity may potentiate the incentive salience of food cues and counteract the effects of satiety cues, thereby increasing feeding.

Keywords: Body mass index; Dopamine D(2) receptor; Food addiction; Obesity; PET; Ventral striatum.

PubMed Disclaimer

Conflict of interest statement

Dr. Nakajima reports having received grants from Japan Society for the Promotion of Science and Inokashira Hospital Research Fund and speaker’s honoraria from GlaxoSmith Kline, Janssen Pharmaceutical, Pfizer, and Yoshitomiyakuhin within the past 3 years. Dr. Graff-Guerrerro currently receives research support from the following external funding agencies: Canadian Institutes of Health Research, the U.S. National Institute of Health, and the Mexico Instituto de Ciencia y Tecnología para la Capital del Conocimiento en el Distrito Federal (ICyTDF). He has also received professional services compensation from Abbott Laboratories, Gedeon-Richter Plc, and Lundbeck; grant support from Janssen; and speaker compensation from Eli Lilly. Mr. Caravaggio, Ms. Raitsin, Dr. Gerretsen, and Dr. Wilson reported no biomedical financial interests or potential conflicts of interest.

Figures

Figure 1
Figure 1
Correlation between body mass index (BMI) and [11C]-(+)-PHNO binding potential nondisplaceable (BPND) in the ventral striatum in the full sample of subjects (n = 26).
Figure 2
Figure 2
The average [11C]-(+)-PHNO binding potential nondisplaceable (BPND) brain maps for persons within the first quartile of body mass index (BMI) (n = 7) and those within the fourth quartile of BMI (n = 7). The range of BMI for the quartiles is as follows: first = 18.6–21.5, fourth = 26.6–28. Persons within the fourth quartile of BMI had significantly greater [11C]-(+)-PHNO BPND in the ventral striatum compared with persons within the first quartile (t12 = 2.213, p = .047).
Figure 3
Figure 3
Correlation between body mass index (BMI) and [11C]-raclo-pride binding potential nondisplaceable (BPND) in the ventral striatum in the full sample of subjects (n = 35).
Figure 4
Figure 4
Correlation between body mass index (BMI) and binding potential nondisplaceable (BPND) in the ventral striatum in the subgroup of subjects (n = 15) scanned with both (A) [11C]-(+)-PHNO and (B) [11C]-raclopride.
See this image and copyright information in PMC

References

    1. Ogden CLCM, Kit BK, Flegal KM. Prevalence of Obesity in the United States, 2009–2010. NCHS Data Brief, No 82. Hyattsville, MD: National Center for Health Statistics; 2012. - PubMed
    1. Volkow ND, Wang G-J, Baler RD. Reward, dopamine and the control of food intake: Implications for obesity. Trends Cogn Sciences. 2011;15:37–46. - PMC - PubMed
    1. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010;13:635–641. - PMC - PubMed
    1. Huang XF, Zavitsanou K, Huang X, Yu Y, Wang H, Chen F, et al. Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity. Behav Brain Res. 2006;175:415–419. - PubMed
    1. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, et al. Brain dopamine and obesity. Lancet. 2001;357:354–357. - PubMed

Publication types

LinkOut - more resources